The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…
Many public health experts suggest that the COVID-19 pandemic will come to a close by the end of 2022, and while it will not disappear, the pandemic will mutate into an endemic disease. This change will mean that most people will have…
Federal legislation of interest to the oral health community was recently included in a hearing held by the U.S. House of Representatives’ Energy and Commerce Committee: the Oral Health Literacy and Awareness Act of 2021 (H.R. 4555).…
At the start of the COVID-19 pandemic, it was clear who was at greatest risk for COVID-19-related mortality and morbidity—older adults and those with preexisting conditions such as diabetes, and where—urban centers with dense populations in…
While the United States is experiencing a much-needed slow down in the number of new COVID-19 cases across the country, a tragic milestone has been met—throughout the globe, more than 5 million people have died due to illness caused by …
New Colgate® Optic White® Professional is extraordinary whitening made simple. Help patients achieve a dramatically whiter smile in just 5 days, when used as directed. ALL-NEW patented technology designed for no tooth sensitivity, no gum…
